← Back to Search

VR experience for Hospice Patients (VRPC Trial)

N/A
Recruiting
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
at least 18 years or older
admitted to Hospice for Specialty Palliative Care
Timeline
Screening 3 weeks
Treatment Varies
Follow Up rr measured immediately before and immediately after each vr experience.
Awards & highlights

VRPC Trial Summary

This trial aims to see if using virtual reality can help improve symptoms in palliative care patients in a hospice. They want to test this on a larger group of patients, including those who are not

Who is the study for?
This trial is for adults over 18 years old who are receiving specialty palliative care in a hospice. It's designed to see if virtual reality can help improve their symptoms.Check my eligibility
What is being tested?
The study tests whether using Virtual Reality (VR) technology can provide symptom relief for patients in palliative care, with an emphasis on both immediate and sustained benefits one week post-VR experience.See study design
What are the potential side effects?
While the trial focuses on VR, potential side effects may include dizziness, nausea, or discomfort due to the immersive nature of VR technology.

VRPC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am admitted to hospice for specialized comfort care.

VRPC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline average esas scores measured one week prior to the vr experience will be compared to the average of esas scores one week following the vr experience.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline average esas scores measured one week prior to the vr experience will be compared to the average of esas scores one week following the vr experience. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety
Secondary outcome measures
VR experience effect on Heart Rate (HR) (part of vital signs) as indicator for Pain and/or Distress
VR experience effect on Mean Arterial Pressure (MAP) (part of vital signs) as indicator for Pain and/or Distress
VR experience effect on Respiratory Rate (RR) (part of vital signs) as indicator for Pain and/or Distress
+1 more

VRPC Trial Design

1Treatment groups
Experimental Treatment
Group I: VR experienceExperimental Treatment1 Intervention
Participants will be given a list of VR applications to choose from. They will then be given instructions by a research assistant (approximately 10 minutes) on how to use the selected application they have chosen, as well as time for any questions they may have before starting their VR experience. They will then have an approximately 30-minute session of that VR experience. They may or may not be accompanied by a family member or significant other and will also have a research assistant available to aid them in any difficulties experienced during the VR experience.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1630

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
243 Previous Clinical Trials
57,560 Total Patients Enrolled
~8 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top